We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
THE LEE COMPANY

Download Mobile App




Revolutionary Genomic Handheld Device Offers First-of-Kind Point-of-Decision, Lab in Cartridge PCR Test

By LabMedica International staff writers
Posted on 08 Nov 2023
Print article
Image: The Lab-in-Cartridge system operates by placing a sample swab into a disposable cartridge that extracts RNA (Photo courtesy of Imperial College London)
Image: The Lab-in-Cartridge system operates by placing a sample swab into a disposable cartridge that extracts RNA (Photo courtesy of Imperial College London)

The world’s first handheld polymerase chain reaction (PCR) genomic diagnostic cartridge and chip offers the potential to transform the diagnosis of infections and cancer risk based on personal genomics at the point of decision.

DnaNudge (London, UK) and NantNudge (Los Angeles, CA, USA) have entered into a multi-million-dollar agreement wherein NantNudge will drive the worldwide adoption of rapid, lab-free point-of-decision diagnostics, targeting regions including the Americas and Africa. The collaboration aims to fulfill the urgent global demand for fast, cost-effective, and user-friendly multiplex RT-PCR testing that works even outside traditional clinical settings. DnaNudge’s Lab-in-Cartridge system simplifies the testing process: a user inserts a swab with a sample into a single-use cartridge that isolates RNA. This cartridge is then analyzed by the NudgeBox, which performs reverse transcription to DNA and delivers results in just over an hour.

Originally designed to combat lifestyle diseases like obesity and Type 2 diabetes, this innovative DNA testing approach has been quickly adapted in response to the COVID-19 pandemic by developing a rapid, lab-free CovidNudge RT-PCR test. The test can identify COVID-19 among other viruses within the same one-hour timeframe and is currently employed in healthcare facilities worldwide. NantNudge will produce the compact, RT-PCR NantCartridge, the NantBeam wearable device, and the NantChip cartridge, which brings the lab to the patient, for medical and consumer health applications. The NantBeam connects to smartphones, offering AI-driven advice on food and product choices based on a person’s unique genomic data.

NantNudge will be focusing on gaining regulatory approvals for the NantCartridge to be used in identifying a range of infectious diseases like COVID-19, influenza, RSV, TB, and bacterial infections, as well as evaluating cancer risks, all through analysis of a person's genomic blueprint at the point of care. NantNudge’s new “Quad” test is set to be released after it clears regulatory review, which will enable the detection of SARS-CoV-2, FluA, FluB, and RSV from just one sample. In addition, there are plans to begin co-developing comprehensive testing kits that work outside the lab, to tackle pressing global health issues including infectious diseases, personalized medicine, cancer, diabetes-related infections, STDs, and antibiotic resistance.

"This is a momentous day, both in terms of DnaNudge's commercial journey and for realizing our ambition of transforming global access to life-changing – and life-saving – near-patient diagnostics,” said Professor Chris Toumazou, Chairman and co-founder of DnaNudge.

"This genomics PCR device, I believe, will be an inflection point for capturing genomic signals on a very personalized basis and transforming how we work, live, and play,” added Dr. Patrick Soon-Shiong, founder of NantWorks and NantNudge.

Related Links:
DnaNudge 
NantNudge 

Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Gold Supplier
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Silver Supplier
Immunoblots for Myositis Diagnostics
EUROLINE Myositis Profiles

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Pathology

view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.